Susquehanna Fundamental Investments’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $32.7K | Buy |
+10,355
| New | +$32.7K | ﹤0.01% | 917 |
|
|
2022
Q1 | $425K | Sell |
28,949
-3,051
| -10% | -$44.8K | 0.01% | 1135 |
|
|
2021
Q4 | $646K | Sell |
32,000
-11,258
| -26% | -$227K | 0.02% | 818 |
|
|
2021
Q3 | $1.18M | Buy |
43,258
+241
| +0.6% | +$6.55K | 0.02% | 801 |
|
|
2021
Q2 | $1.05M | Buy |
+43,017
| New | +$1.05M | 0.02% | 840 |
|
|
2021
Q1 | – | Sell |
-8,252
| Closed | -$264K | – | 1517 |
|
|
2020
Q4 | $264K | Sell |
8,252
-23,978
| -74% | -$767K | ﹤0.01% | 1288 |
|
|
2020
Q3 | $1.06M | Buy |
32,230
+6,352
| +25% | +$210K | 0.03% | 621 |
|
|
2020
Q2 | $1.21M | Buy |
+25,878
| New | +$1.21M | 0.06% | 407 |
|